176 related articles for article (PubMed ID: 30882150)
1. Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal.
Rijal KR; Adhikari B; Ghimire P; Banjara MR; Das Thakur G; Hanboonkunupakarn B; Imwong M; Chotivanich K; Day NPJ; White NJ; Pukrittayakamee S
J Infect Dis; 2019 Jul; 220(3):448-456. PubMed ID: 30882150
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
[TBL] [Abstract][Full Text] [Related]
3. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
7. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
8. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
[TBL] [Abstract][Full Text] [Related]
9. Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.
Wangchuk S; Drukpa T; Penjor K; Peldon T; Dorjey Y; Dorji K; Chhetri V; Trimarsanto H; To S; Murphy A; von Seidlein L; Price RN; Thriemer K; Auburn S
Malar J; 2016 May; 15(1):277. PubMed ID: 27176722
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
Hwang J; Alemayehu BH; Reithinger R; Tekleyohannes SG; Takele Teshi ; Birhanu SG; Demeke L; Hoos D; Melaku Z; Kassa M; Jima D; Malone JL; Nettey H; Green M; Poe A; Akinyi S; Udhayakumar V; Kachur SP; Filler S
PLoS One; 2013; 8(5):e63433. PubMed ID: 23717423
[TBL] [Abstract][Full Text] [Related]
14. Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
Thanh PV; Hong NV; Van NV; Louisa M; Baird K; Xa NX; Peeters Grietens K; Hung le X; Duong TT; Rosanas-Urgell A; Speybroeck N; D'Alessandro U; Erhart A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7411-9. PubMed ID: 26392501
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response.
Mekonnen DA; Abadura GS; Behaksra SW; Taffese HS; Bayissa GA; Bulto MG; Tessema TS; Tadesse FG; Gadisa E
Malar J; 2023 Apr; 22(1):135. PubMed ID: 37098510
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
19. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.
Durand S; Cabezas C; Lescano AG; Galvez M; Gutierrez S; Arrospide N; Alvarez C; Santolalla ML; Bacon DJ; Graf PC
Am J Trop Med Hyg; 2014 Jul; 91(1):18-26. PubMed ID: 24752682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
